|
|
Volumn 47, Issue 10, 2008, Pages 1334-1338
|
|
Somatostatin analogs for the treatment of advanced, hormone-refractory prostate cancer: A possibility for secondary hormonal ablation?;Somatostatin-analoga in der therapie des fortgeschrittenen hormonrefraktären prostatakarzinoms: Eine möglichkeit der sekundären hormonablation?
a
b
a
a
c
c
|
|
Author keywords
Diagnosis; Prognosis; Prostate cancer; Secondary hormonal manipulation; Therapy
|
|
Indexed keywords
ANDROGEN;
ANGIOPEPTIN;
ANTIANDROGEN;
CORTICOTROPIN;
DEXAMETHASONE;
ESTRAMUSTINE;
ESTROGEN;
ETOPOSIDE;
GESTAGEN;
GONADORELIN DERIVATIVE;
GROWTH HORMONE;
INTERLEUKIN 6;
OCTREOTIDE;
PROSTATE SPECIFIC ANTIGEN;
SOMATOMEDIN B;
SOMATOMEDIN C;
SOMATOSTATIN DERIVATIVE;
SOMATOSTATIN RECEPTOR 1;
SOMATOSTATIN RECEPTOR 2;
SOMATOSTATIN RECEPTOR 3;
SOMATOSTATIN RECEPTOR 4;
SOMATOSTATIN RECEPTOR 5;
TAMOXIFEN;
TAXANE DERIVATIVE;
TRANSFORMING GROWTH FACTOR BETA1;
TRIPTEROLIN;
UNCLASSIFIED DRUG;
ACROMEGALY;
ADVANCED CANCER;
APOPTOSIS;
ARTICLE;
BREAST CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DIABETES MELLITUS;
DIABETOGENESIS;
DRUG CYTOTOXICITY;
DRUG MECHANISM;
DRUG TREATMENT FAILURE;
GASTROINTESTINAL TUMOR;
HORMONE INHIBITION;
HUMAN;
INSULIN RELEASE;
NEUROSECRETORY CELL;
PROSTATE CANCER;
QUALITY OF LIFE;
SIGNAL TRANSDUCTION;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BONE NEOPLASMS;
CELL PROLIFERATION;
DISEASE PROGRESSION;
DRUG DELIVERY SYSTEMS;
HUMANS;
MALE;
NEOPLASM STAGING;
NEOPLASMS, HORMONE-DEPENDENT;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
SOMATOSTATIN;
SURVIVAL RATE;
|
|
EID: 53249117476
PISSN: 03402592
EISSN: None
Source Type: Journal
DOI: 10.1007/s00120-008-1781-7 Document Type: Article |
|
Times cited : (3)
|
|
References (31)
|
